摘要
胆管癌(CCA)是影响胆道上皮的异质性发育障碍组。它是第二常见的原发性肝肿瘤,占所有胃肠癌的3%左右。由于其积极性,晚期诊断和高耐化学性,CCA非常致命。全球的发病率正在增加,治疗方案非常有限。放射治疗,化疗,手术和/或肝移植可能在符合某些标准的患者中显示,但成功率很低。因此,越来越有兴趣了解参与这种癌症类型的发病机理的分子机制以及鉴定新的治疗靶标。目前的策略是基于涉及增殖,存活,凋亡和迁移的关键信号通路。在这篇综述中,讨论了涉及CCA发病机制的最相关的分子机制,并强调了主要的临床前和临床研究。此外,还指出了基础和临床研究的未来发展方向。
关键词: 胆道上皮,胆管癌,癌症,发病机制,基质,分子机制,治疗
图形摘要
Current Drug Targets
Title:Molecular Mechanisms of Cholangiocarcinogenesis: New Potential Targets for Therapy
Volume: 18 Issue: 8
关键词: 胆道上皮,胆管癌,癌症,发病机制,基质,分子机制,治疗
摘要: Cholangiocarcinoma (CCA) is a heterogeneous group of dysplastic disorders affecting the biliary epithelium. It is the second most common primary liver tumor which accounts for around 3% of all gastrointestinal cancers. CCA is very deadly due to its aggressiveness, late diagnosis and high chemoresistance. The incidence is increasing worldwide and the therapeutic options are very limited. Radiotherapy, chemotherapy, surgery and/or liver transplantation may be indicated in patients who meet certain criteria, but chances of success are low. There is therefore increasing interest in understanding the molecular mechanisms involved in the pathogenesis of this cancer type and in identifying new targets for therapy. Current strategies are based on targeting key signaling pathways involved in proliferation, survival, apoptosis and migration. In this review, the most relevant molecular mechanisms involved in the pathogenesis of CCA are discussed and the main preclinical and clinical studies are highlighted. Moreover, future directions in basic and clinical research are indicated.
Export Options
About this article
Cite this article as:
Molecular Mechanisms of Cholangiocarcinogenesis: New Potential Targets for Therapy, Current Drug Targets 2017; 18 (8) . https://dx.doi.org/10.2174/1389450116666150825113035
DOI https://dx.doi.org/10.2174/1389450116666150825113035 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Triphenylethylene-Coumarin Hybrid TCH-5c Suppresses Tumorigenic Progression in Breast Cancer Mainly Through the Inhibition of Angiogenesis
Anti-Cancer Agents in Medicinal Chemistry Pharmacogenomics in Colorectal Cancer
Current Pharmacogenomics Recent Updates on Biological Activities of Oxadiazoles
Mini-Reviews in Medicinal Chemistry Carbonic Anhydrases as Drug Targets - An Overview
Current Topics in Medicinal Chemistry Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis
Current Stem Cell Research & Therapy Towards the Development of Anticancer Drugs from Andrographolide: Semisynthesis, Bioevaluation, QSAR Analysis and Pharmacokinetic Studies
Current Topics in Medicinal Chemistry A proteomics based approach for the identification of gastric cancer related markers
Current Pharmaceutical Design Exosomal microRNAs as Potentially Useful Tools in Cancer Biomarker Discovery
Recent Patents on Biomarkers G Protein-Coupled Receptors in Regulation of Body Weight
CNS & Neurological Disorders - Drug Targets Lumiflavin Enhances the Effects of Ionising Radiation on Ovarian Cancer Stem-Like Cells by Inhibiting Autophagy
Anti-Cancer Agents in Medicinal Chemistry Carbonic Anhydrase Based Biomarkers: Potential Application in Human Health and Environmental Sciences
Current Biomarkers (Discontinued) Molecular Signatures of Biomarkers in Cancer Development, Diagn osis, and its Prognostic Accuracy
Current Biomarkers (Discontinued) MicroRNA-34a and its target genes: Key factors in cancer multidrug resistance
Current Pharmaceutical Design An Update of Radiolabeled Bombesin Analogs for Gastrin-Releasing Peptide Receptor Targeting
Current Pharmaceutical Design Anticancer Drugs Targeting the Apoptotic Pathway
Medicinal Chemistry Reviews - Online (Discontinued) Newly Identified Tumor Antigens as Promising Cancer Vaccine Targets for Malignant Melanoma Treatment
Current Topics in Medicinal Chemistry Multifunctionalized Microbubbles for Cancer Diagnosis and Therapy
Anti-Cancer Agents in Medicinal Chemistry Towards the Development of Tumor Necrosis Factor (TNF) Sensitizers:Making TNF Work Against Cancer
Current Pharmaceutical Design Quercetin in Attenuation of Ischemic/Reperfusion Injury: A Review
Current Molecular Pharmacology Exploiting Novel Cell Cycle Targets in the Development of Anticancer Agents
Current Cancer Drug Targets